Scott Newsome, DO, MSCS, FAAN

Scott Newsome, DO, MSCS, FAAN, specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He has special interest in evaluating and treating patients with multiple sclerosis (MS), transverse myelitis, neuromyelitis optica, and stiff person syndrome. He works within the Division of Neuroimmunology and Neuroinfectious Diseases at Johns Hopkins Hospital. He joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis centers after completing his fellowship, and he is currently the director of the Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center, and is co-director of the Multiple Sclerosis Experimental Therapeutics Program, all at Johns Hopkins.

Dr Newsome received his medical degree from the New York College of Osteopathic Medicine (currently known as the New York Institute of Technology College of Osteopathic Medicine) and graduated with honors. He then completed his internship in internal medicine and residency in neurology at Albany Medical Center. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship from the National MS Society.

Dr Newsome’s main research focuses on helping to identify and test novel therapies and therapeutic strategies in MS and other neuroimmunological disorders. In addition, other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in MS and identifying risk factors of disease onset and severity, response to treatment, and long-term outcomes in neuroimmunological disorders. Currently, Dr Newsome is involved in several clinical trials for MS, transverse myelitis, and neuromyelitis optica. He is also serving as treasurer of the Consortium of Multiple Sclerosis Centers, is an advisor for the National MS Society Clinical Advisory Committee, and is a member of the Miller-Coulson Academy of Clinical Excellence.